Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

2007 Journal of the American College of Cardiology 489 citations

Keywords

ClopidogrelMedicineAcute coronary syndromeInternal medicineTolerabilityAspirinMyocardial infarctionLoading doseCardiologyP2Y12AnesthesiaAdverse effect

Affiliated Institutions

Related Publications

Publication Info

Year
2007
Type
article
Volume
50
Issue
19
Pages
1844-1851
Citations
489
Access
Closed

External Links

Citation Metrics

489
OpenAlex

Cite This

Christopher P. Cannon, Steen Husted, Robert A. Harrington et al. (2007). Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome. Journal of the American College of Cardiology , 50 (19) , 1844-1851. https://doi.org/10.1016/j.jacc.2007.07.053

Identifiers

DOI
10.1016/j.jacc.2007.07.053